
29. Schnier, C., Janbek, J., Lathe, R., and Haas, J. (2022). Reduced demen-
tia incidence after varicella zoster vaccination in Wales 2013–2020. Alz-
heimers Dement. (N Y) 8, e12293. https://doi.org/10.1002/trc2.12293.
30. Wiemken, T.L., Salas, J., Morley, J.E., Hoft, D.F., Jacobs, C., and Scher-
rer, J.F. (2022). Comparison of rates of dementia among older adult re-
cipients of two, one, or no vaccinations. J. Am. Geriatr. Soc. 70, 1157–
1168. https://doi.org/10.1111/jgs.17606.
31. Lophatananon, A., Carr, M., Mcmillan, B., Dobson, C., Itzhaki, R., Parisi,
R., Ashcroft, D.M., and Muir, K.R. (2023). The association of herpes zos-
ter and influenza vaccinations with the risk of developing dementia: a
population-based cohort study within the UK Clinical Practice Research
Datalink. BMC Public Health 23, 1903. https://doi.org/10.1186/s12889-
023-16768-4.
32. Ukraintseva, S., Yashkin, A.P., Akushevich, I., Arbeev, K., Duan, H., Gor-
bunova, G., Stallard, E., and Yashin, A. (2024). Associations of infections
and vaccines with Alzheimer’s disease point to a role of compromised
immunity rather than specific pathogen in AD. Exp. Gerontol. 190,
112411. https://doi.org/10.1016/j.exger.2024.112411.
33. Lehrer, S., and Rheinstein, P.H. (2021). Herpes Zoster Vaccination Re-
duces Risk of Dementia. In Vivo 35, 3271–3275. https://doi.org/10.
21873/invivo.12622.
34. Wilkinson, T., Schnier, C., Bush, K., Rannikma¨ e, K., Lyons, R.A., McTag-
gart, S., Bennie, M., and Sudlow, C.L. (2022). Drug prescriptions and de-
mentia incidence: a medication-wide association study of 17000 demen-
tia cases among half a million participants. J. Epidemiol. Community
Health 76, 223–229. https://doi.org/10.1136/jech-2021-217090.
35. Tang, E., Ray, I., Arnold, B.F., and Acharya, N.R. (2024). Recombinant
zoster vaccine and the risk of dementia. Vaccine 46, 126673. https://
doi.org/10.1016/j.vaccine.2024.126673.
36. Remschmidt, C., Wichmann, O., and Harder, T. (2015). Frequency and
impact of confounding by indication and healthy vaccinee bias in obser-
vational studies assessing influenza vaccine effectiveness: a systematic
review. BMC Infect. Dis. 15, 429. https://doi.org/10.1186/s12879-015-
1154-y.
37. Pomirchy, M., Bommer, C., Pradella, F., Michalik, F., Peters, R., and
Geldsetzer, P. (2025). Herpes Zoster Vaccination and Dementia Occur-
rence. JAMA 333, 2083–2092. https://doi.org/10.1001/jama.2025.5013.
38. SAIL Databank. (2024). https://saildatabank.com/.
39. Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary
Care. (2023). https://healthdatagateway.org/en/dataset/355.
40. Statistical Directorate (2011). Welsh Index of Multiple Deprivation 2011:
Summary Report (Welsh Government).
41. Cattaneo, M.D., Keele, L., and Titiunik, R. (2023). A guide to regression
discontinuity designs in medical applications. Stat. Med. 42, 4484–
4513. https://doi.org/10.1002/sim.9861.
42. Cattaneo, M.D., Idrobo, N., and Titiunik, R. (2020). A Practical Introduc-
tion to Regression Discontinuity Designs: Foundations (Cambridge Uni-
versity Press).
43. Villamizar-Villegas, M., Pinzon-Puerto, F.A., and Ruiz-Sanchez, M.A.
(2022). A comprehensive history of regression discontinuity designs:
An empirical survey of the last 60 years. J. Econ. Surv. 36, 1130–1178.
https://doi.org/10.1111/joes.12461.
44. Global Burden of Disease Project 2019. (2020). GBD Compare. http://
vizhub.healthdata.org/gbd-compare.
45. Fro
¨
lich, M., and Huber, M. (2019). Including Covariates in the Regression
Discontinuity Design. J. Bus. Econ. Stat. 37, 736–748. https://doi.org/10.
1080/07350015.2017.1421544.
46. Charlson, M.E., Pompei, P., Ales, K.L., and MacKenzie, C.R. (1987). A
new method of classifying prognostic comorbidity in longitudinal studies:
development and validation. J. Chronic Dis. 40, 373–383. https://doi.org/
10.1016/0021-9681(87)90171-8.
47. National Institute for Health and Care Excellence (2018). Dementia:
Assessment, Management and Support for People Living with Dementia
and Their Carers (National Institute for Health and Care Excellence).
48. Lang, L., Clifford, A., Wei, L., Zhang, D., Leung, D., Augustine, G., Danat,
I.M., Zhou, W., Copeland, J.R., Anstey, K.J., et al. (2017). Prevalence and
determinants of undetected dementia in the community: a systematic
literature review and a meta-analysis. BMJ Open 7, e011146. https://
doi.org/10.1136/bmjopen-2016-011146.
49. van Vliet, D., de Vugt, M.E., Bakker, C., Pijnenburg, Y., van Vliet, D., de
Vugt, M.E., Bakker, C., Pijnenburg, Y.A., Vernooij-Dassen, M.J., Koop-
mans, R.T., and Verhey, F.R. (2013). Time to diagnosis in young-onset
dementia as compared with late-onset dementia. Psychol. Med. 43,
423–432. https://doi.org/10.1017/S0033291712001122.
50. Chiari, A., Tondelli, M., Galli, C., Carbone, C., Fiondella, L., Salemme, S.,
Vinceti, G., Bedin, R., Molinari, M.A., and Zamboni, G. (2022). How long
does it take to diagnose young-onset dementia? A comparison with late-
onset dementia. Neurol. Sci. 43, 4729–4734. https://doi.org/10.1007/
s10072-022-06056-1.
51. Chen, Y., Power, M.C., Grodstein, F., Capuano, A.W., Lange-Maia, B.S.,
Moghtaderi, A., Stapp, E.K., Bhattacharyya, J., Shah, R.C., Barnes, L.L.,
et al. (2024). Correlates of missed or late versus timely diagnosis of de-
mentia in healthcare settings. Alzheimers Dement. 20, 5551–5560.
https://doi.org/10.1002/alz.14067.
52. Helvik, A.-S., Engedal, K.,
�
Saltyt
_
e Benth, J., and Selbæk, G. (2018). Time
from Symptom Debut to Dementia Assessment by the Specialist Health-
care Service in Norway. Dement. Geriatr. Cogn. Dis. Extra 8, 117–127.
https://doi.org/10.1159/000487233.
53. Centers for Disease Control and Prevention. (2022). Archived CDC Vac-
cine Price List as of June 1, 2018. Adult Vaccine Price List. https://www.
cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-
list/2018/2018-06-01.html.
54. Singhal, P.K., and Zhang, D. (2014). Costs of adult vaccination in medical
settings and pharmacies: an observational study. J. Manag. Care Spec.
Pharm. 20, 930–936. https://doi.org/10.18553/jmcp.2014.20.9.930.
55. Prosser, L.A., Harpaz, R., Rose, A.M., Gebremariam, A., Guo, A., Ortega-
Sanchez, I.R., Zhou, F., and Dooling, K. (2019). A Cost-Effectiveness
Analysis of Vaccination for Prevention of Herpes Zoster and Related
Complications: Input for National Recommendations. Ann. Intern. Med.
170, 380–388. https://doi.org/10.7326/M18-2347.
56. Bricout, H., Haugh, M., Olatunde, O., and Prieto, R.G. (2015). Herpes
zoster-associated mortality in Europe: a systematic review. BMC Public
Health 15, 466. https://doi.org/10.1186/s12889-015-1753-y.
57. Eyting, M., Xie, M., Heß, S., and Geldsetzer, P. (2023). Causal evidence
that herpes zoster vaccination prevents a proportion of dementia cases.
Preprint at medRxiv. https://doi.org/10.1101/2023.05.23.23290253.
58. Harbecke, R., Cohen, J.I., and Oxman, M.N. (2021). Herpes Zoster Vac-
cines. J. Infect. Dis. 224, S429–S442. https://doi.org/10.1093/infdis/
jiab387.
59. Fleming, D.M., Cross, K.W., Cobb, W.A., and Chapman, R.S. (2004).
Gender difference in the incidence of shingles. Epidemiol. Infect. 132,
1–5. https://doi.org/10.1017/s0950268803001523.
60. Marra, F., Parhar, K., Huang, B., and Vadlamudi, N. (2020). Risk Factors
for Herpes Zoster Infection: A Meta-Analysis. Open Forum Infect. Dis. 7,
ofaa005. https://doi.org/10.1093/ofid/ofaa005.
61. Ferretti, M.T., Martinkova, J., Biskup, E., Benke, T., Gialdini, G., Nedel-
ska, Z., Rauen, K., Mantua, V., Religa, D., Hort, J., et al. (2020). Sex
and gender differences in Alzheimer’s disease: current challenges and
implications for clinical practice: Position paper of the Dementia and
Cognitive Disorders Panel of the European Academy of Neurology. Eur.
J. Neurol. 27, 928–943. https://doi.org/10.1111/ene.14174.
62. Ferretti, M.T., Iulita, M.F., Cavedo, E., Chiesa, P.A., Schumacher Dimech,
A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., Gia-
cobini, E., et al. (2018). Sex differences in Alzheimer disease - the
OPEN ACCESS
14 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article